Zelira Therapeutics Limited - Australian Company Profile

What does Zelira Therapeutics Limited do?

Zelira Therapeutics is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2024 the company generated total revenue of $95,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Zelira Therapeutics is Mr Oludare Odumosu whose official title is Managing Director & Global Chief Executive Officer. The Chairman of Zelira Therapeutics is Mr Osaige Imasogie whose official title is Chairman.

Zelira Therapeutics Limited is an ASX listed pharmaceutical (medicinal cannabis) company, conducting clinical trial research and selling a range of pharmaceutical products. The research conducted, examines patients with breast, brain and pancreatic cancer as well as diabetes. Patients with autism, insomnia and chronic pain are also examined in the trials. The company also offers a range of pharmaceutical products used by doctors, pharmacists and patients, operating in Australia and the USA. The company's main proprietary medications include: ZENIVOL - Cannabinoid drug for the treatment of chronic insomnia. HOPE - Cannabinoid drug for treatment of Autism. RAF FIVE - Acne treatment products. SprinJeneCBD - Oral care products.

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Zelira Therapeutics Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Zelira Therapeutics Limited by position type and title.

Enterprise Financials

Get a full view of Zelira Therapeutics Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Zelira Therapeutics Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Zelira Therapeutics Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Zelira Therapeutics Limited operates in.

Competitor Benchmarking

Compare Zelira Therapeutics Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Zelira Therapeutics Limited.

Subsidiaries

View a list of Zelira Therapeutics Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Zelira Therapeutics Limited, including founding information, past announcements, mergers and major projects.